Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
GlaxoSmithKline PLC ADS
(NY:
GSK
)
52.97
USD
+0.24 (+0.46%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
1,283,412
Open
52.42
Bid (Size)
52.95 (400)
Ask (Size)
52.96 (200)
Prev. Close
52.73
Today's Range
52.38 - 53.07
52wk Range
41.68 - 53.45
Shares Outstanding
2,698,797,984
Dividend Yield
3.94%
Top News
More News
Week in Review: Hisun-Pfizer and Merck-Simcere JVs Come Into Focus
May 25, 2013
Zhejiang Hisun Pharma contributed 75 drug products to gain 51% control of its JV with Pfizer, while Pfizer added eight drugs; the Merck-Simcere JV is focused onsix cardiovascular drugs, two from...
Read More
from
ChinaBio® Today
Movers and Shakers: A look at who in bio is coming and going
May 24, 2013
The following personnel announcements at New England-area biotech companies have been made in recent weeks: Cambridge, Mass...
Read More
category
Edward Myles
,
John Reynders
,
Biotech
, and 9 more.
from
Business Journals
More News
Read More
Spinning RECORD: Battle Over Rosiglitazone Heats Up Two Weeks Before Crucial FDA Meeting
May 24, 2013
category
NYSE:GSK
from
Forbes Real Time
Glaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia
May 23, 2013
category
NYSE:GSK
from
Forbes Real Time
The FDA Responds To Steve Nissen's Criticism Of Upcoming Avandia Meeting
May 23, 2013
category
NYSE:GSK
from
Forbes Real Time
UPDATE 2-Elan rejects Royalty's $6.4 bln raised offer
May 23, 2013
category
companyNews
from
Reuters: Company News
4 Contagion Plays
May 23, 2013
category
NYSE:NVS
,
NYSE:SNY
,
NYSE:GSK
, and 1 more.
from
Forbes Real Time
Pharma Continues To Seek External R&D Funding, This Time from The Government
May 23, 2013
category
NYSE:PFE
,
NYSE:GSK
from
Forbes Real Time
Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings
May 23, 2013
category
NYSE:GSK
from
Forbes Real Time
GSK flu shot may raise adult narcolepsy risk -Finnish scientists
May 23, 2013
category
companyNews
from
Reuters: Company News
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.